Financhill
Buy
66

ABT Quote, Financials, Valuation and Earnings

Last price:
$129.81
Seasonality move :
3.27%
Day range:
$127.13 - $132.89
52-week range:
$99.71 - $141.23
Dividend yield:
1.76%
P/E ratio:
16.97x
P/S ratio:
5.41x
P/B ratio:
4.72x
Volume:
8.8M
Avg. volume:
7.9M
1-year change:
20.68%
Market cap:
$225.2B
Revenue:
$42B
EPS (TTM):
$7.65

Earnings Data

Next earnings date for ABT
Jul 18
2025
Most recent earnings per share
$5.27
Beat by $3.93
(Jan 22/2025)
Consensus Estimate
$1.34
(Jan 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ABT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/18/2025 Q2 $11B -- -- $1.25 --
04/16/2025 Q1 $10.4B -- -- $1.07 --
01/22/2025 Q4 $11B $11B $5.27 $1.34 $3.93
10/16/2024 Q3 $10.6B $10.6B $0.94 $1.20 -$0.26
07/18/2024 Q2 $10.4B $10.4B $0.74 $1.10 -$0.36
04/17/2024 Q1 $9.9B $10B $0.70 $0.95 -$0.25
01/24/2024 Q4 $10.2B $10.2B $0.91 $1.19 -$0.28
10/18/2023 Q3 -- -- $0.82 $1.10 -$0.28
07/20/2023 Q2 -- -- $0.78 $1.05 -$0.27
04/19/2023 Q1 -- -- $0.75 $0.99 -$0.24
01/25/2023 Q4 -- -- $0.59 $0.94 -$0.35
10/19/2022 Q3 -- -- $0.81 $0.94 -$0.13
07/20/2022 Q2 -- -- $1.14 $1.14 -$0.00
04/20/2022 Q1 -- -- $1.37 $1.46 -$0.09
01/26/2022 Q4 -- -- $1.11 $1.21 -$0.10
10/20/2021 Q3 -- -- $1.17 $0.95 $0.22
07/22/2021 Q2 -- -- $0.66 $1.02 -$0.36
04/20/2021 Q1 -- -- $1.00 $1.27 -$0.27
01/27/2021 Q4 -- -- $1.20 -- --
10/21/2020 Q3 -- -- $0.69 -- --
07/16/2020 Q2 -- -- $0.30 -- --
04/16/2020 Q1 -- -- $0.31 -- --
01/22/2020 Q4 -- -- $0.59 -- --
10/16/2019 Q3 -- -- $0.53 -- --
07/17/2019 Q2 -- -- $0.56 -- --
04/17/2019 Q1 -- -- $0.38 -- --
01/23/2019 Q4 -- -- $0.37 -- --
10/17/2018 Q3 -- -- $0.32 -- --
07/18/2018 Q2 -- -- $0.41 -- --
04/18/2018 Q1 -- -- $0.23 -- --
01/24/2018 Q4 -- -- -$0.48 -- --
10/18/2017 Q3 -- -- $0.34 -- --
07/20/2017 Q2 -- -- $0.16 -- --
04/19/2017 Q1 -- -- $0.24 -- --
01/25/2017 Q4 -- -- $0.53 -- --
10/19/2016 Q3 -- -- -$0.22 -- --
07/20/2016 Q2 -- -- $0.41 -- --
04/20/2016 Q1 -- -- $0.21 -- --
01/28/2016 Q4 -- -- $0.51 -- --
10/21/2015 Q3 -- -- $0.38 -- --
07/22/2015 Q2 -- -- $0.52 -- --

Abbott Laboratories Earnings Questions

  • How Much did Abbott Laboratories Generate in Revenue Last Quarter?

    Abbott Laboratories reported $11B worth of top line sales in its most recent quarter.

  • Did Abbott Laboratories Beat Earnings Last Quarter?

    Abbott Laboratories announced earnings per share of $5.27 which represents a beat of analyst forecast a $1.34 per share.

  • Is Abbott Laboratories Profitable?

    Abbott Laboratories reported $6B that represents $3.46 per share over the last quarter.

  • What is the Analyst Consensus for Abbott Laboratories EPS Next Year?

    Abbott Laboratories's earnings are forecast to decrease from $7.64 per share to $4.67 per share next year representing a decrease of -32.62%.

  • When is Abbott Laboratories's Earnings Date?

    Abbott Laboratories's next earnings date is July 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Intel Struggling Against AMD?
Why Is Intel Struggling Against AMD?

Due to its disappointing reports, so-so management, and lack of…

Will PayPal Stock Recover or Keep Sliding?
Will PayPal Stock Recover or Keep Sliding?

Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…

How High Will Eli Lilly Stock Go By 2030?
How High Will Eli Lilly Stock Go By 2030?

The weight loss drugs market is heating up quickly and…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
49
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 35x

Alerts

Buy
71
PEGA alert for Apr 24

Pegasystems [PEGA] is up 28.8% over the past day.

Buy
67
SMMT alert for Apr 24

Summit Therapeutics [SMMT] is up 21.57% over the past day.

Sell
36
ENPH alert for Apr 24

Enphase Energy [ENPH] is down 15.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock